<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04795973</url>
  </required_header>
  <id_info>
    <org_study_id>2021-IF-11</org_study_id>
    <nct_id>NCT04795973</nct_id>
  </id_info>
  <brief_title>Efficacy of Intermittent Fasting on Weight Loss and Related Metabolic Parameters in Adults With Overweight or Obesity</brief_title>
  <official_title>Efficacy of Intermittent Fasting on Weight Loss and Related Metabolic Parameters in Adults With Overweight or Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To elucidate the health effects, and further explore the research on safety. This study was&#xD;
      conducted among adults with overweight or obesity by using the intermittent fasting for 4&#xD;
      weeks. The aim of this study was to provide scientific basis for the IF combined with walking&#xD;
      exercise used as a new prevention and control technology for the overweight and obesity&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, overweight and obese people were consecutively enrolled. The subjects accepted&#xD;
      the intermittent fasting intervention for 4 weeks. Therefore, by comparing and analysising&#xD;
      the morphological indexes (height, weight, waist circumference, hip circumference, body fat&#xD;
      percentage, the waist to hip ratio and body mass index), blood pressure, heart rate, blood&#xD;
      and urine biochemical index, dietary behavior, and other indicators before and after the&#xD;
      intervention. And thus evaluate the effect of intervention and adverse reactions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Adults aged between 18 to 75 years old without diabetes. 25&lt;BMI&lt;35 kg/m2</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight</measure>
    <time_frame>baseline and 4 weeks</time_frame>
    <description>the change of weight</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>baseline and 4 weeks</time_frame>
    <description>the change of waist circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hip circumference</measure>
    <time_frame>baseline and 4 weeks</time_frame>
    <description>the change of hip circumference</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Intermittent Fasting</condition>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>IF group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intermittent fasting intervention for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>intermittent fasting</intervention_name>
    <description>intermittent fasting: choose two non-consecutive days per week to eat very little</description>
    <arm_group_label>IF group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults aged between 18 to 75 years old without diabetes. 25&lt;BMI&lt;35 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diet therapy before participation. liver function impairment. renal function&#xD;
             impairment. cancer. pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guang Wang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jia Liu</last_name>
    <phone>01085231217</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yu An</last_name>
    <phone>01085231217</phone>
    <email>anyu900222@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>BeijingCYH</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guang Wang</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Guang Wang</investigator_full_name>
    <investigator_title>Director of Endocrinology</investigator_title>
  </responsible_party>
  <keyword>Intermittent Fasting</keyword>
  <keyword>Overweight and Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

